| Health care resource utilization and cost burden of hemophilia B in the United States TW Buckner, I Bocharova, K Hagan, AG Bensimon, H Yang, EQ Wu, ... Blood Advances 5 (7), 1954-1962, 2021 | 22 | 2021 |
| Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States Z Zhou, KA Betts, I Bocharova, D Kinrich, WM Spalding Journal of Attention Disorders, 2018 | 21 | 2018 |
| Comparative efficacy of first-line ceritinib and crizotinib in advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer: an adjusted indirect … J Li, S Knoll, I Bocharova, W Tang, J Signorovitch Current medical research and opinion 35 (1), 105-111, 2019 | 19 | 2019 |
| Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study E Bendaly, AA Dalal, K Culver, P Galebach, I Bocharova, R Foster, ... Advances in therapy 34, 1145-1156, 2017 | 18 | 2017 |
| HSR19-084: Real-World Treatment Patterns and Clinical Outcomes in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations M DerSarkissian, S Li, A Galaznik, R Bhak, I Bocharova, T Kulalert, ... Journal of the National Comprehensive Cancer Network 17 (3.5), HSR19-084, 2019 | 8 | 2019 |
| The Impact of Progression on Healthcare Resource Utilization and Costs Among Patients with High-Grade Non-Muscle Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy … M Yang, MV Georgieva, I Bocharova, M Vembusubramanian, K Qian, ... Advances in Therapy 38, 1584-1600, 2021 | 6 | 2021 |
| Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer Patients E Bendaly, AA Dalal, K Culver, P Galebach, I Bocharova, R Foster, ... Advances in Therapy 34, 1673-1685, 2017 | 6 | 2017 |
| Disease progression among patients who receive available bladder preservation therapies after failure of BCG therapy in the SEER-Medicare data AM Kamat, MV Georgieva, J Song, I Bocharova, K Qian, A Guo, M Yang Journal of Clinical Oncology 38 (6_suppl), 453-453, 2020 | 5 | 2020 |
| Comparative efficacy of first-line ceritinib and alectinib in advanced ALK+ NSCLC: A cross-study indirect comparison CPK Chan, J Li, S Knoll, W Tang, I Bocharova, J Signorovitch Annals of Oncology 29, ix163, 2018 | 2 | 2018 |
| Development of a Predictive Model for Hyperkalemia K Betts, MJ Woolley, F Mu, I Bocharova, AG Bensimon, E Wu American Society of Nephrology Kidney Week, ABSTRACT: SA-PO433, 2017 | 2 | 2017 |
| Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma M DerSarkissian, H Cranmer, J Dabora, I Bocharova, D Cherepanov, ... Hematology 28 (1), 2156731, 2023 | 1 | 2023 |
| Sub-optimal outcomes with switching to zidovudine vs. recycling tenofovir in second-line treatment in Haiti S Pierre, C Nguyen, B Iryna, F Homeus, V Guillaume, CPJ Pierre, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 23, 19-20, 2020 | 1 | 2020 |
| P3. 02a-007 Monitoring for and Characteristics of Crizotinib Progression: A Chart Review of ALK+ Non-Small Cell Lung Cancer Patients: Topic: ALK Biomarkers E Bendaly, A Dalal, K Culver, P Galebach, I Bocharova, R Foster, ... Journal of Thoracic Oncology 12 (1), S1163, 2017 | 1 | 2017 |
| Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti S Pierre, I Bocharova, C Nguyen, F Homeus, G Julmiste, Y Macius, ... Open Forum Infectious Diseases 8 (12), ofab559, 2021 | | 2021 |
| P-190: A systematic literature review and indirect treatment comparison among randomized clinical trials to estimate the relative efficacy of treatments for relapsed/refractory … R Bhak, H Cranmer, J Dabora, I Bocharova, D Cherepanov, M Cheng, ... Clinical Lymphoma Myeloma and Leukemia 21, S141-S142, 2021 | | 2021 |
| A US payer database algorithm to identify clinical profiles of hemophilia B for burden of illness assessment NN Li, I Bocharova, AG Bensimon, EQ Wu, EK Sawyer, TW Buckner National Hemophilia Foundation - 72nd Bleeding Disorders Conference, 2020 | | 2020 |
| PRO49 Development of an algorithm to identify clinical profiles of hemophilia B in a US payer claims database N Li, I Bocharova, AG Bensimon, EQ Wu, EK Sawyer, TW Buckner Value in Health 23, S337, 2020 | | 2020 |
| PCN62 Disease burden associated with progression in patients with high-grade non-muscle invasive bladder cancer receiving bladder preserving therapies after adequate BCG … M Yang, MV Georgieva, I Bocharova, M Vembusubramanian, K Qian, ... Value in Health 23, S34, 2020 | | 2020 |
| PCN42 Treatment patterns and survival among patients with BCG unresponsive high-grade non-muscle invasive bladder cancer: An assessment of the SEER-Medicare data M Yang, J Song, M Georgieva, I Bocharova, K Qian, A Guo, AM Kamat Value in Health 23, S30, 2020 | | 2020 |
| Contemporary Data on Incidence, Treatments and Outcomes of Tis, High-Grade Ta, and High-Grade T1 Non-Muscle Invasive Bladder Cancer Patients in the US J Song, MV Georgieva, I Bocharova, E Wu, A Guo, S Spigelman, ... New England Section of the American Urological Association, 88th Annual …, 2019 | | 2019 |
Ashish M. Kamat, MD, MBBS, FACSProfessor, MD Anderson Cancer CenterVerified email at mdanderson.org
